• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于调整后的风险因素,对中国女性乳腺癌死亡率和伤残调整生命年(1990-2015 年)进行的分层年龄-时期-队列分析。

A Hierarchical Age-Period-Cohort Analysis of Breast Cancer Mortality and Disability Adjusted Life Years (1990-2015) Attributable to Modified Risk Factors among Chinese Women.

机构信息

Department of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, Wuhan 430071, China.

Department of Zoology, University of Gujrat, Gujrat 50700, Pakistan.

出版信息

Int J Environ Res Public Health. 2020 Feb 20;17(4):1367. doi: 10.3390/ijerph17041367.

DOI:10.3390/ijerph17041367
PMID:32093283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7068251/
Abstract

Limited studies quantified the age, period, and cohort effects attributable to different risk factors on mortality rates (MRs) and disability-adjusted life years (DALYs) due to breast cancer among Chinese women. We used data from the Global Burden of Disease Study (GBD) in 2017. Mixed-effect and hierarchical age-period-cohort (HAPC) models were used to assess explicit and implicit fluctuations in MRs and DALYs attributable to different breast cancer associated risk factors. As the only risk factor, high body mass index (HBMI) showed continuously increasing trends in MRs and DALYs across ages, periods, and cohorts. Age, recent periods (2010-2015), and risk factor HBMI showed significant positive effect on MRs and DALYs ( < 0.05). Moreover, we reported significant interaction effects of older age and period in recent years in addition to the interplay of older age and risk factor HBMI on MRs and DALYs. Increased age and obesity contribute to substantially raised breast cancer MRs and DALYs in China and around the globe. These discoveries shed light on protective health policies and provision of healthy lifestyle for improving the subsequent breast cancer morbidity and mortality for China, as well as other related Asian regions that are presently facing the same public health challenges.

摘要

有限的研究量化了归因于不同危险因素的年龄、时期和队列效应对中国女性乳腺癌死亡率 (MR) 和伤残调整生命年 (DALY) 的影响。我们使用了 2017 年全球疾病负担研究 (GBD) 的数据。混合效应和分层年龄-时期-队列 (HAPC) 模型用于评估归因于不同乳腺癌相关危险因素的 MR 和 DALY 的明确和隐含波动。作为唯一的危险因素,高身体质量指数 (HBMI) 在年龄、时期和队列方面的 MR 和 DALY 呈持续上升趋势。年龄、近期时期 (2010-2015 年) 和危险因素 HBMI 对 MR 和 DALY 有显著的正向影响 (<0.05)。此外,我们还报告了在近年来的高龄和近期时期之间存在显著的交互作用效应,以及高龄和危险因素 HBMI 对 MR 和 DALY 的相互作用效应。年龄的增长和肥胖导致中国乃至全球乳腺癌的 MR 和 DALY 显著上升。这些发现为制定保护健康的政策和提供健康的生活方式提供了启示,以改善中国以及其他面临同样公共卫生挑战的亚洲相关地区的乳腺癌发病率和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edfb/7068251/5dca716d3183/ijerph-17-01367-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edfb/7068251/007fbea13205/ijerph-17-01367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edfb/7068251/a248afbf4dca/ijerph-17-01367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edfb/7068251/f76d816c1299/ijerph-17-01367-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edfb/7068251/5dca716d3183/ijerph-17-01367-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edfb/7068251/007fbea13205/ijerph-17-01367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edfb/7068251/a248afbf4dca/ijerph-17-01367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edfb/7068251/f76d816c1299/ijerph-17-01367-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edfb/7068251/5dca716d3183/ijerph-17-01367-g004.jpg

相似文献

1
A Hierarchical Age-Period-Cohort Analysis of Breast Cancer Mortality and Disability Adjusted Life Years (1990-2015) Attributable to Modified Risk Factors among Chinese Women.基于调整后的风险因素,对中国女性乳腺癌死亡率和伤残调整生命年(1990-2015 年)进行的分层年龄-时期-队列分析。
Int J Environ Res Public Health. 2020 Feb 20;17(4):1367. doi: 10.3390/ijerph17041367.
2
Evaluation of lifestyle risk factor differences in global patterns of breast cancer mortality and DALYs during 1990-2017 using hierarchical age-period-cohort analysis.利用分层年龄-时期-队列分析评估 1990-2017 年全球乳腺癌死亡率和伤残调整生命年(DALYs)的生活方式风险因素差异模式。
Environ Sci Pollut Res Int. 2021 Sep;28(36):49864-49876. doi: 10.1007/s11356-021-14165-1. Epub 2021 May 3.
3
Disease burden of liver cancer attributable to specific etiologies in China from 1990 to 2019: An age-period-cohort analysis.中国 1990 年至 2019 年特定病因归因于肝癌的疾病负担:一项年龄-时期-队列分析。
Sci Prog. 2021 Apr-Jun;104(2):368504211018081. doi: 10.1177/00368504211018081.
4
The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.2019 年全球 195 个国家和地区因超重导致的疾病负担:基于全球疾病负担研究的分析。
PLoS Med. 2020 Jul 28;17(7):e1003198. doi: 10.1371/journal.pmed.1003198. eCollection 2020 Jul.
5
Historical trends of breast cancer burden attributable to metabolic factors among Chinese women, 1990-2019: A population-based epidemiological study.中国女性归因于代谢因素的乳腺癌负担的历史趋势,1990-2019:基于人群的流行病学研究。
Thorac Cancer. 2024 Jun;15(16):1279-1286. doi: 10.1111/1759-7714.15316. Epub 2024 Apr 25.
6
Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.1990-2013 年期间青少年健康的疾病、伤害及危险因素全球负担:2013 年全球疾病负担研究系统分析。
Lancet. 2016 Jun 11;387(10036):2383-401. doi: 10.1016/S0140-6736(16)00648-6. Epub 2016 May 9.
7
The temporal trend of disease burden attributable to metabolic risk factors in China, 1990-2019: An analysis of the Global Burden of Disease study.1990 - 2019年中国代谢风险因素所致疾病负担的时间趋势:全球疾病负担研究分析
Front Nutr. 2023 Jan 4;9:1035439. doi: 10.3389/fnut.2022.1035439. eCollection 2022.
8
Trends in deaths and disability-adjusted life-years of stroke attributable to high body-mass index worldwide, 1990-2019.1990 - 2019年全球因高体重指数导致的中风死亡及伤残调整生命年趋势
Front Neurol. 2023 Jun 30;14:1211642. doi: 10.3389/fneur.2023.1211642. eCollection 2023.
9
Ischemic heart disease deaths, disability-adjusted life years and risk factors in Fujian, China during 1990-2013: Data from the Global Burden of Disease Study 2013.1990 - 2013年中国福建省缺血性心脏病死亡、伤残调整生命年及风险因素:来自《2013年全球疾病负担研究》的数据
Int J Cardiol. 2016 Jul 1;214:265-9. doi: 10.1016/j.ijcard.2016.03.236. Epub 2016 Apr 4.
10
Epidemiological trend and age-period-cohort effects on cardiovascular disease mortality and disability-adjusted life years attributable to dietary risks and high body mass index at the regional and country level across China and Pakistan.中国和巴基斯坦区域及国家层面上,饮食风险和高体重指数所致心血管疾病死亡率及伤残调整生命年的流行病学趋势和年龄-时期-队列效应
Front Nutr. 2023 Jun 6;10:1158769. doi: 10.3389/fnut.2023.1158769. eCollection 2023.

引用本文的文献

1
The Safety and Efficacy of Anticancer Therapy in Breast Cancer Patients with Liver Cirrhosis.抗癌疗法对肝硬化乳腺癌患者的安全性与有效性
Cancer Manag Res. 2025 Mar 19;17:639-650. doi: 10.2147/CMAR.S503109. eCollection 2025.
2
Trends in deaths and disability-adjusted life-years of ischemic heart disease attributable to high body-mass index worldwide, 1990-2019.高身体质量指数与全球缺血性心脏病所致死亡和伤残调整生命年变化趋势,1990-2019 年。
BMC Cardiovasc Disord. 2024 Sep 11;24(1):482. doi: 10.1186/s12872-024-04136-y.
3
Trends in breast cancer mortality attributable to metabolic risks in Chinese women from 1990 to 2019: an age-period-cohort analysis.

本文引用的文献

1
Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model.利用年龄-时期-队列模型对四个亚洲国家乳腺癌发病率趋势的最新见解。
Cancer Manag Res. 2019 Sep 3;11:8145-8155. doi: 10.2147/CMAR.S208323. eCollection 2019.
2
Survival analysis of breast cancer patients with different treatments: a multicentric clinicopathological study.不同治疗方法的乳腺癌患者生存分析:一项多中心临床病理研究。
J Pak Med Assoc. 2019 Jul;69(7):976-980.
3
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
1990年至2019年中国女性代谢风险所致乳腺癌死亡率趋势:年龄-时期-队列分析
Front Oncol. 2024 Apr 16;14:1369027. doi: 10.3389/fonc.2024.1369027. eCollection 2024.
4
Breast cancer prediction using different machine learning methods applying multi factors.应用多因素的不同机器学习方法进行乳腺癌预测。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17133-17146. doi: 10.1007/s00432-023-05388-5. Epub 2023 Sep 29.
5
association with higher plasma 4-hydroxy tamoxifen in Pakistani (estrogen-positive) breast cancer patients.与巴基斯坦(雌激素阳性)乳腺癌患者血浆中 4-羟基他莫昔芬水平升高有关。
Exp Biol Med (Maywood). 2023 Sep;248(17):1507-1517. doi: 10.1177/15353702231187640. Epub 2023 Sep 9.
6
Global trends and forecasts of breast cancer incidence and deaths.全球乳腺癌发病与死亡趋势及预测。
Sci Data. 2023 May 27;10(1):334. doi: 10.1038/s41597-023-02253-5.
7
Secular trends in the mortality of gastrointestinal cancers across China, Japan, the US, and India: An age-period-cohort, Joinpoint analyses, and Holt forecasts.中国、日本、美国和印度胃肠道癌死亡率的长期趋势:年龄-时期-队列分析和霍尔特预测。
Front Public Health. 2022 Sep 29;10:925011. doi: 10.3389/fpubh.2022.925011. eCollection 2022.
8
Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea.中国 1990 年至 2019 年乳腺癌发病负担、趋势及风险因素分析,以及对 2034 年的预测:与日本和韩国的最新比较综述
BMC Cancer. 2022 Jul 29;22(1):826. doi: 10.1186/s12885-022-09923-4.
9
Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis.1990 年至 2017 年 21 个世界区域和全球女性乳腺癌发病率、死亡率、病死率和伤残调整寿命年的流行病学和社会人口学变化:年龄-时期-队列分析。
J Adv Res. 2021 Aug 2;37:185-196. doi: 10.1016/j.jare.2021.07.012. eCollection 2022 Mar.
10
Lifestyle and Socioeconomic Transition and Health Consequences of Breast Cancer in the East Asia Region, From 1990 to 2019.1990年至2019年东亚地区乳腺癌的生活方式、社会经济转变及健康后果
Front Nutr. 2022 Apr 11;9:817836. doi: 10.3389/fnut.2022.817836. eCollection 2022.
死亡率、发病率和风险因素在中国及其省份,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2019 Sep 28;394(10204):1145-1158. doi: 10.1016/S0140-6736(19)30427-1. Epub 2019 Jun 24.
4
Epidemiological characteristics of and risk factors for breast cancer in the world.全球乳腺癌的流行病学特征及危险因素
Breast Cancer (Dove Med Press). 2019 Apr 10;11:151-164. doi: 10.2147/BCTT.S176070. eCollection 2019.
5
An insight into clinical outcome of XPG polymorphisms in breast cancer.乳腺癌中XPG基因多态性的临床结局洞察。
Mol Biol Rep. 2018 Dec;45(6):2369-2375. doi: 10.1007/s11033-018-4401-7. Epub 2018 Sep 25.
6
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.印度各邦癌症负担及其变化:1990-2016 年全球疾病负担研究。
Lancet Oncol. 2018 Oct;19(10):1289-1306. doi: 10.1016/S1470-2045(18)30447-9. Epub 2018 Sep 12.
7
Mortality and years of life lost due to breast cancer attributable to physical inactivity in the Brazilian female population (1990-2015).由于缺乏身体活动导致的巴西女性人群乳腺癌死亡人数和寿命损失年数(1990-2015 年)。
Sci Rep. 2018 Jul 24;8(1):11141. doi: 10.1038/s41598-018-29467-7.
8
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数,1990 年至 2016 年:全球疾病负担研究的系统分析。
JAMA Oncol. 2018 Nov 1;4(11):1553-1568. doi: 10.1001/jamaoncol.2018.2706.
9
Ovarian cancer statistics, 2018.卵巢癌统计数据,2018 年。
CA Cancer J Clin. 2018 Jul;68(4):284-296. doi: 10.3322/caac.21456. Epub 2018 May 29.
10
The hierarchical age-period-cohort model: Why does it find the results that it finds?分层年龄-时期-队列模型:为何会得出这样的结果?
Qual Quant. 2018;52(2):783-799. doi: 10.1007/s11135-017-0488-5. Epub 2017 Feb 24.